DNA diagnostics is a technique used to detect and analyze the biological
markers in the proteome and genome by applying the theory of microbiology. The
utilization of this technique was initialised in early 1990’s. This technique
is extensively used for detecting and testing of infectious, genetic and
chronic diseases. Early disease detection and prevention becomes easy by the
DNA diagnostics in order to increase the efficiency of chronic disease
identification.
Some of the key factors that are driving the growth are increasing the
prevalence of several types of cancers, myogenic diseases and infectious
disease, acceptance or personalised medicines and improving molecular
technology. In addition, increasing awareness of DNA diagnosis, continuous
development of biomarkers and early stage curing of cancers are propelling
growth and is expected to grow significantly over the forecast period. Furthermore,
innovation in the proteomics & molecular technology, and reformed
reimbursement policy is fuelling the over the past few years. However, the high
cost of DNA diagnostics integration, lack of skill to handle complex & new
platforms and stringent regulatory framework is restraining the growth. An
increasing number of cancer patients, rapid shifting to personalised medicines
from traditional diagnostics are key opportunities for players to propel
expansion.
Browse Full Report @ https://www.hexaresearch.com/upcoming-research/dna-diagnostics-market
DNA diagnostics sector is segregated on the basis of its product into
three types such as isolation & purification kits, software & service,
instruments, and amplification kits. Owing to growing acceptance of DNA
diagnosis, advanced healthcare facilities, competitive cost framework and
availability of instruments have dominated the instrument segment. Software
& service segment is expected to witness significant growth on account of
technological advancement and rising interference of information technology
over the forecast period. On the basis of technology, this sector is segmented
into five technologies including mass spectrometry, DNA sequencing, PCR,
in-situ hybridization, microarray and fingerprinting. Fingerprinting technology
is further divided into polymerase chain reaction and fragment length
polymorphism. Owing to the ability to separate and isolating property from collected
samples PCR technology has the largest share.
The industry is classified on the basis of applications into
disease diagnostics, paternity testing, and forensics and organ
transplantation. Disease diagnostics had acquired the highest share in 2015 and
is expected to grow significantly over the forecast period owing to increasing
rate of infectious disease, different types of cancers and myogenic
diseases. The industry is segregated into four segments on the basis of
end-user applications such as self-testing or OTC, diagnostic laboratories,
hospitals, the point of care and research laboratories. The hospital has
acquired the maximum share of the market in 2015 on account of increasing use
of diagnostics tests for the detection of the disease.
Browse Category Related Market Reports @ https://www.hexaresearch.com/research-category/biotechnology-industry
North America was estimated to account for the highest share in 2015,
followed by Europe, Asia Pacific, and rest of the world. Owing to the presence
of high technology infrastructure, investments in the development healthcare
infrastructure and governments endeavour along with the high prevalence of
chronic disease is propelling the growth of the North American sector. Asia
Pacific is expected to experience significant growth owing to increasing
funding for the healthcare infrastructure, rising population and increase in
disposable income of population over the forecast period. In addition,
continuous R&D activities in the DNA testing research and government
initiative for the prevalence of chronic disease in this region will fuel
expansion.
Some of the key market players in this market are Abbott Laboratories,
Roche Diagnostics, Thermo Fisher Scientific, Gene-Probe Inc., Novartis,
Illumina Inc., Cephide, Johnson and Johnson, Sysmex, Bio-rad laboratories, and
Bayer Diagnostic. Innovative products are being introduced in the market, as
the players are launching new products in the market. Some of the key players
are also entering into collaborations, partnerships and agreements with the
hospitals & laboratories to strengthen their market position, enhance the
market presence and gain a competitive edge over other players.
Widespread use of these techniques in various applications along with
the higher incidence rates of chronic disease and increasing awareness of
personalised medicines are key trends which will be expected to fuel the growth
of DNA diagnostics industry over the forecast period. The major companies such
as Abbott Laboratories, Roche Diagnostics, Thermo Fisher Scientific, Gene-Probe
Inc., Novartis, Illumina Inc., Cephide, Johnson and Johnson, Sysmex, Bio-rad
laboratories, and Bayer Diagnostic are expected to dominate the market over the
forecast period owing to their continuous efforts intended to design and
emphasize on new product developments to accommodate the consumer demand. This
industry is expected to become highly competitive over the forecast period owing
to the fact that it is driven by incorporation of new technologies and
development of cost-effective products.
Browse Full Report @ https://www.hexaresearch.com/upcoming-research/dna-diagnostics-market
About Us:
Hexa Research is a market research and consulting organization, offering
industry reports, custom research and consulting services to a host of key
industries across the globe. We offer comprehensive business intelligence in
the form of industry reports which help our clients obtain clarity about their
business environment and enable them to undertake strategic growth initiatives.
Contact Us:
Ryan Shaw
Hexa Research
Felton Office Plaza
6265 Highway 9
Felton, California 95018
United States
Phone: +1-800-489-3075
Email: sales@hexaresearch.com
Website - http://www.hexaresearch.com/
Follow
us on Linkedin : https://www.linkedin.com/company/hexa-research 
No comments:
Post a Comment